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Objective To evaluate the effects of the combination butorphanol, 
medetomidine and midazolam (BMM) and its reversibility in lions. 
Abstract: 
Study design prospective clinical trial 
Animals Thirty free-ranging lions, 10 male and 20 female, weighing 81 - 210 
kg. 
Methods Lions were immobilised with butorphanol mean 0.31 ± SD 0.034 mg 
kg-1, medetomidine 0.052 ± 0.006 mg kg-1, midazolam 0.21 ± 0.024 mg kg-1 and 
hyaluronidase 1250 IU administered intramuscularly with a dart gun. Upon 
recumbency, physiological parameters and anaesthetic depth were monitored 
10 to 15 minutes after darting (T1) and repeated every 10 minutes for a further 
30 minutes (T2, T3, T4). Arterial blood gas analyses were performed at T1 and 
T4. At the end of the procedure, 45 to 60 minutes after initial darting, 
immobilisation was reversed with naltrexone 0.68 ± 0.082 mg kg-1, atipamezole 
0.26 ± 0.031 mg kg-1, and flumazenil 0.0032 ± 0.0007 mg kg-1 administered 
intravenously and subcutaneously. 
Results The BMM combination rapidly induced immobilisation and lateral 
recumbency was reached within 7.25 ± 2.3 minutes. Median induction score 
(scored 1 (excellent) - 4 (poor)) was 1.4 (range 1 - 2). Cardio-respiratory 
parameters were stable. Heart rate varied from 32 - 72 beats per minute, 
respiratory rate from 14 - 32 breaths per minute and rectal temperature from 
36.6 - 40.3°C. No sudden arousals were observed. Blood gas analyses 
revealed a mean pH of 7.333, PaCO2 of 33 mmHg and PaO2 of 87 mmHg. Mild 
to moderate hypoxemia was seen in four lions. Recovery was smooth and lions 
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were walking within 4.4 ± 4.25 minutes. Median recovery score (scored 1 
(excellent) - 4 (poor)) was 1.3 (range 1 - 2).  
Conclusion and clinical relevance The drug combination proved to be 
effective in immobilising free-ranging healthy lions of both sexes with minimal 





 lion, medetomidine, butorphanol, midazolam, atipamezole, 
naltrexone, flumazenil 




Safe and reliable immobilisation of African lions (Panthera leo) is an important 
tool for conservation-based programmes of free-ranging animals. Lions are 
anaesthetised routinely for sample collection, disease surveillance, research 
studies and treatment (Herbst et al. 1985; Fahlman et al. 2005; Jacquier et al. 
2006). Ideally, drugs used for the capture of free-ranging animals should induce 
immobilisation rapidly and reliably, provide stable cardio-respiratory function, 
and be fully reversible. Darted lions can be difficult to locate following a 
prolonged induction, especially if working in dense bush or at night, and they 
are vulnerable to unfavourable environmental conditions, injury or attack from 
other lions and predators during both the induction and recovery periods. The 
use of immobilising drug combinations which can be antagonised facilitates the 
management of adverse drug responses.  
 
Various drugs and drug combinations have been used both in free-ranging and 
captive lions. In the 1970’s, lions were immobilised using phencyclidine 
hydrochloride which tended to cause convulsions and resulted in very 
prolonged recovery periods (Bush et al. 1978). More recently, ketamine, often in 
combination with xylazine or medetomidine, has been used for the purpose, 
especially for lions held in captivity. Sudden recoveries without warning, 
bradycardia, vomiting and large dart volumes are drawbacks seen with these 
combinations (Herbst et al. 1985; Stander & Morkel 1991; Tomizawa et al. 
1997; Quandt 2005). Tiletamine-zolazepam has been used for the 
immobilisation of free-ranging lions, but used alone, can cause prolonged and 
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uncoordinated inductions and recoveries (King et al. 1977; Stander & Morkel 
1991). When medetomidine is combined with tiletamine/zolazepam, the 
duration of immobilisation can be shortened and induction is smoother 
(Fahlman et al. 2005; Jacquier et al. 2006).  
 
Combinations of medetomidine 0.01 - 0.05 mg kg-1, butorphanol 0.1 - 0.4 mg 
kg-1 and midazolam or diazepam 0.15 - 1 mg kg-1 have been used successfully 
to immobilise domestic and exotic carnivore species, such as red wolf (Canis 
rufus), African wild dog (Lycaon pictus), cheetah (Acinonyx jubatus) and 
California sea lion (Zalophus californianus) (Verstegen & Petcho 1993; Larsen 
et al. 2002; Kalema-Zikusoka et al. 2003; Williams et al. 2003; Spelman 2004; 
Lafortune et al. 2005; Fleming et al. 2006). These combinations provided stable 
anaesthesia with good analgesia and muscle relaxation lasting for at least 40 
minutes. Side effects included bradycardia, hypertension, hypoventilation, 
hypoxaemia, hypo- and hyperthermia and metabolic acidosis (Pypendop et al. 
1996; Pypendop & Verstegen 1999; Larsen et al. 2002; Kalema-Zikusoka et al. 
2003). Reversal of anaesthesia was rapid using either atipamezole alone or in 
combination with flumazenil and naltrexone or naloxone (Verstegen & Petcho 
1993; Williams et al. 2003; Spelman 2004; Lafortune et al. 2005; Fleming et al. 
2006). These results suggest that this combination would be applicable in larger 
carnivores, including lions.  
 
The aim of this study was to evaluate the effects of the combination 
butorphanol, medetomidine and midazolam (BMM) and its reversibility using 
naltrexone, atipamezole and flumazenil in free-ranging lions.  
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Material and Methods 
 
The project was approved by Scientific Services of South African National Parks 
and complied with the Animal Use and Care Committee approved standard 
operating procedure (SOP) for the “Capture, transportation and maintenance in 
holding facilities of wildlife”. 
 
Twelve male and twenty one female African lions were immobilised in order to 
test for bovine tuberculosis (Mycobacterium bovis) and to collect blood and 
tissue samples in Kruger National Park, South Africa. One female and two male 
animals were excluded from the study due to poor dart placement resulting in 
subcutaneous drug delivery. All individuals were considered healthy based on 
physical examination during immobilisation. The lions were attracted to a 
capture site in the evening using a zebra carcass as bait and playing a tape-
recording of hyenas feeding at a kill as described previously (Smuts et al. 1977; 
McKenzie & Burroughs 1993). When a suitable lion was sighted, its body mass 
was estimated and a 3-mL dart (Dan-Inject International, South Africa) 
prepared. The intent was to administer medetomidine 0.05 mg kg-1 
(Medetomidine 20 mg mL-1), butorphanol 0.3 mg kg-1 (Butorphanol 50 mg mL-1), 
midazolam 0.2 mg kg-1 (Midazolam 50 mg mL-1), and hyaluronidase 1250 IU 
(Hyalase), all drugs sourced from Kyron Laboratories (Pty) Ltd, South Africa. 
Once the selected lion was feeding calmly at the carcass, it was darted from a 
vehicle intramuscularly (IM) in the upper hind leg or shoulder area using a CO2 
pressurised dart gun (Dan-Inject International, South Africa) from a distance of 
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10 - 20 m. The times to initial effect, sternal and lateral recumbency following 
the administration of the immobilising drugs were recorded. A descriptive score 
ranging from 1 (excellent) to 4 (poor) was used to assess induction quality 
(Table 1). It was noted if the animal had to be followed with a vehicle into the 
bush and if vomiting occurred.  
 
Once a lion was recumbent, it was stimulated with a pole to determine if 
it was sufficiently immobilised and safe to handle. The lion was loaded onto a 
vehicle and moved away from the remaining animals at the carcass so that it 
could be monitored and samples collected in safety. The animal was blindfolded 
and the forelimbs hobbled. Physiological parameters and anaesthetic depth 
were measured 10 to 15 minutes after darting (T1) and repeated every 10 
minutes for a further 30 minutes (T2, T3, T4). Respiratory rate (fR) was 
monitored by observing chest movements and heart rate (HR) was obtained by 
auscultation of the heart. Body temperature was measured with a digital 
thermometer (Hartmann Thermoval thermometer, Top Draw Healthcare (Pty) 
Limited, South Africa) inserted rectally. A pulse oximeter (TidalGuardTM Sp, 
SHARN Veterinary, Inc., Germany) was attached to the tongue to measure 
relative haemoglobin oxygen saturation in the blood (SpO2). An endotracheal 
tube (size 5mm) was inserted into the ventral nasal passage and connected to a 
sidestream capnograph (TidalGuardTM Sp, SHARN Veterinary, Inc., Germany) 
to measure end-tidal CO2 (PE`CO2). Depth of immobilisation was assessed 
using palpebral, pedal and anal reflexes, jaw tone, presence of voluntary tail 
movements and reaction to painful stimuli such as ear notching. The level of 
immobilisation was evaluated using a descriptive score ranging from 1 (limited 
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effect) to 6 (excessive level) (Table 2). Body weight, body condition and sex 
were recorded and the lions were aged by the method according to Smuts et al. 
(1978). Tissue (hair and ear notches) and blood samples were collected. 
 
At times T1 and T4 blood was withdrawn from a femoral artery into a 
heparinised 1 mL syringe and immediately analysed using a portable blood gas 
analyser (i-STAT ®1 Analyzer, i-STAT Corporation, New Jersey, USA) and 
disposable cartridges (i-STAT CG 4 cartridges, Abbott Point of Care, Inc., 
Illinois, USA). Variables measured included pH, partial pressure of carbon 
dioxide (PaCO2), partial pressure of oxygen (PaO2) and lactate. Base excess, 
bicarbonate (HCO3) and arterial haemoglobin saturation (SaO2) were calculated 
from the measured values. Analyses were corrected to body temperature. To 
assess gas exchange the alveolar to arterial oxygen pressure gradient P(A-a)O2 
was calculated as the difference between the calculated alveolar partial 
pressure (PAO2) and the measured PaO2. The actual barometric pressures 
(ranging between 730 and 744 mmHg) were used to calculate the inspired 
partial pressure of oxygen.  
 
At the end of the procedure, 45 to 60 minutes after initial darting, 
immobilisation was reversed using naltrexone (Naltrexone, 50 mg mL-1, Kyron 
Laboratories, South Africa), atipamezole (Antisedan, Orion Pharma, Finland) 
and flumazenil (Anexate, Roche Products, South Africa). Naltrexone was given 
intravenously (IV) at 2.2 times the butorphanol dose, atipamezole at 5 times the 
medetomidine dose (half of the dose was administered IV and the rest 
subcutaneously (SC)), and flumazenil at 0.016 mg per 1 mg of midazolam IV. 
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The first three lions received only 0.008 mg flumazenil per 1 mg of midazolam. 
The times to first head lift, sternal recumbency and standing/walking after 
administration of the drug antagonists were recorded. Quality of recovery was 
assessed using a scoring system (Table 3). 
 
Statistical analyses 
Statistical analyses were performed using PASW, version 18.0 (SPSS Inc., 
Chicago, Illinois 60606, USA). Induction, recovery and immobilisation scores 
were not normally distributed and are presented as median values plus range. 
Other data were normally distributed, and are presented as mean values + 
standard deviation, with range where relevant. Pearson correlation coefficient 
was used (a) to determine correlation between medetomidine, butorphanol and 
midazolam doses in mg kg-1 with induction and recovery times and scores, and 
with monitored variables during immobilisation; (b) compare differences 
between PaCO2 and PE`CO2, and with fR obtained manually and from the 
capnograph; (c) to detect any correlation between P(A-a)O2 gradients, body 
weight and PaO2. Paired T-test was used to determine differences in blood gas 
values between sampling times (T1 and T4). Repeated measures ANOVA and 
post hoc Bonferroni was used to check for differences in HR, fR , SpO2 and 
temperatures through time (T1, T2, T3, T4). Mann Whitney U Test was used to 
detect differences in induction scores between animals that moved after darting 
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Data from ten male lions weighing 163 ± 46.6 kg (range 88 to 210 kg) and aged 
6.0 ± 2.8 years (range 15 months to ten years), and from twenty female animals 
weighing 133 ± 19.8 kg (range 81 to 165 kg) and aged 6.4 ± 1.9 years (range 
two to nine years) were used in this study. The combination of BMM rapidly 
induced immobilisation in all lions and no additional doses were needed. Mean 
medetomidine dose was 0.052 ± 0.006 mg kg-1 (range 0.042 - 0.064 mg kg-1), 
mean butorphanol dose was 0.31 ± 0.034 mg kg-1 (range 0.26 - 0.38 mg kg-1) 
and mean midazolam dose was 0.21 ± 0.024 mg kg-1 (range 0.17 - 0.26 mg kg-
1). First signs of initial drug effect were observed within 3.1 ± 1.2 minutes (range 
1.3 - 5.8 minutes) and included swaying of the torso, an ataxic gait and lowering 
of the head. Sternal recumbency was reached within 4.9 ± 1.5 minutes (range 
2.0 - 9.0 minutes) and lateral recumbency within 7.25 ± 2.3 minutes (range 2.2 - 
11.3 minutes) after darting. There was no correlation between the variations in 
the BMM dose in mg kg-1 and the range of induction times recorded. Median 
induction score was 1.4 (range 1 - 2) on a scale of 1 to 4 and induction was 
rated excellent in 18 out of 30 lions. Lions that stayed near the bait had a 
significantly better quality of induction (median induction score 1.2, range 1 - 2) 
than animals that had to be tracked into the bush and were disturbed by the 
following vehicle (median induction score 1.8, range 1 - 2) (p = 0.002). Eight 
lions remained in sternal recumbency and never attained lateral recumbency. 
No vomiting occurred during the induction period. 
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 Immobilisation was stable and no spontaneous movements or sudden 
arousals were observed. Median immobilisation score was 4.5 (range 3 – 5) on 
a scale of 1 to 6 at all time points. There was no reaction to any of the painful 
stimuli applied during the procedures. Some lions reacted with minimal shaking 
of the head at T1 when the endotracheal tube was inserted into the ventral 
nasal passage. HR varied from 32 - 72 beats per minute (T1: 53 ± 8.5, T2: 53 ± 
9.4, T3: 52 ± 9.4 and T4: 52 ± 8.7), fR from 14 - 32 breaths per minute (T1: 22 ± 
3.2, T2: 21 ± 3.0, T3: 20 ± 2.7 and T4: 20 ± 2.7) and rectal temperature from 
36.6 - 40.3°C (T1: 38.3 ± 0.55, T2: 38.7 ± 0.70, T3: 38.7 ± 0.77 and T4: 38.8 ± 
0.81). Bradyarrhythmias were observed in five lions which had heart rates 
below 50 beats per minute. Two lions had a body temperature above 39.9°C. 
SpO2 ranged between 76 and 100% (T1: 92 ± 4.6, T2: 93 ± 3.4, T3: 94 ± 2.4 
and T4: 93 ± 2.9) and correlated with the SaO2 values obtained from the arterial 
blood gas analyses (p=0.01). SpO2 values below 90% were recorded in 8 out of 
116 samples. Measurement of PE`CO2 nasally varied between 9 - 36 mmHg 
(T1: 21 ± 5.6, T2: 21 ± 5.6, T3: 20 ± 5.7 and T4: 20 ± 5.8) and there was no 
correlation with PaCO2 values (p=0.66). The fR calculated by the capnograph 
corresponded well with the fR  measured through observing the chest 
movements (p<0.001). There was no correlation between differences in BMM 
dose in mg kg-1 and immobilisation score, HR, fR, temperature, SpO2 and 
PE`CO2. No significant differences were seen in HR, temperatures and SpO2 
through time. At T1, fR was significantly higher than at T2, T3 and T4 (p=0.002). 
The difference in fR between subsequent time groups was not significant.  
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 The results of the blood gas analyses are summarised in Table 4. 
Samples taken at T1 and T4 revealed mild metabolic acidosis, normocapnia, 
and mean PaO2 values of 84 ± 9.4and 89 ± 8.3 mmHg respectively. In four out 
of 28 samples PaO2 values were below 80 mmHg at T1 and three out of 29 at 
T4. Lactate levels were significantly higher in the first measurement compared 
with the second sample (P<0.0001). There was no correlation between 
variations in BMM dose in mg kg-1 and pH, PaCO2, PaO2, bicarbonate, base 
excess and lactate. There was a significant negative correlation between SaO2 
and BMM dose in mg kg-1 at T4 (p=0.002), but not at T1. There was no 
correlation between P(A-a)O2 gradients, body weight and PaO2. 
 
 Immobilisation was reversed with atipamezole 0.26 ± 0.031 mg kg-1 
(range 0.21 - 0.32 mg kg-1), naltrexone 0.68 ± 0.082 mg kg-1 (range 0.55 - 0.85 
mg/kg) and flumazenil 0.0032 ± 0.0007 mg kg-1 (range 0.001 - 0.004 mg kg-1). 
First head lift was observed within 3.9 ± 4.1 minutes (range 1.3 - 21.0 minutes), 
sternal recumbency was reached within 4.2 ± 4.3 minutes (range 1.4 - 22 
minutes) and lions were standing and walking within 4.4 ± 4.25 minutes (range 
1.7 - 22 minutes) after reversal. Twenty seven lions were walking within 10 
minutes after the antagonists were given. There was no correlation between 
variations in BMM dose in mg kg-1 and the range of recovery times. Eight lions 
lay down again within 3 - 12 minutes after initial recovery and were walking 2 - 6 
minutes later. Median recovery score was 1.3 (range 1 – 2) on a scale of 1 to 4 
and recovery was rated excellent in 17 out of 30 lions. Eleven animals showed 
a very abrupt recovery and were standing within seconds of lifting their head. 
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One animal vomited two minutes after standing up, but did not seem adversely 
affected as it went back to the carcass to feed within minutes of vomiting. No 






The BMM combination induced stable immobilisation lasting at least 45 minutes 
in the lions. Mean induction time was rapid (less than 8 minutes). The doses 
used in this study were based on research using BMM in cheetah, wild dogs, 
red wolves, ring-tailed lemurs and patas monkeys, and resulted in comparable 
induction times (Larsen et al. 2002; Kalema-Zikusoka et al. 2003; Williams et al. 
2003; Lafortune et al. 2005; Fleming et al. 2006). Similar induction periods have 
been observed in free-ranging lions using medetomidine in combination with 
tiletamine-zolazepam or ketamine (Fahlman et al. 2005; Quandt 2005; Jacquier 
et al. 2006). Longer induction periods up to 30 minutes were seen when 
tiletamine-zolazepam was used alone or with ketamine combined with xylazine 
(King et al. 1977; Herbst et al. 1985; Fahlman et al. 2005; Quandt 2005; 
Jacquier et al. 2006). Induction was smooth in all our lions and no excitation or 
vomiting occurred. In contrast, inductions in which animals ran aimlessly or 
rolled on the ground have been reported in lions immobilised with tiletamine-
zolazepam, phencyclidine and xylazine-ketamine (Herbst et al. 1985; Quandt 
2005). In the present study, hyaluronidase was added to the immobilising 
combination to enhance the absorption and distribution of the injected drugs, 
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and therefore shorten the induction period. This addition resulted in reduced 
induction times when added to the immobilising mixture in black rhinoceros and 
moose (Haigh 1979; Kock 1992). The induction times seen in our lions were 
similar to other species using BMM and it is not clear if the addition of 
hyaluronidase shortened the induction period. 
 
 The level of immobilisation was reliable in all lions and the animals did 
not react to painful stimuli. With this BMM combination procedures such as ear-
notching or tissue sampling were possible, but for more invasive surgeries 
additional drugs may be required. The animals showed no signs of arousal and 
maintained the same immobilisation level throughout the procedure. Stable 
anaesthesia without a need for additional doses is a major advantage for 
personnel safety when working with lions. In comparison, other authors using 
medetomidine-ketamine and tiletamine-zolazepam-medetomidine reported 
sudden recovery and spontaneous movements requiring further doses of drugs 
(Fahlman et al. 2005; Quandt 2005). Two of the three animals that were 
excluded from this study due to subcutaneous dart placement and prolonged 
drug absorption, were initially not administered the antidotes. Samples were 
collected and the lions were then monitored from a distance. Four hours later 
the lions showed only minimal reaction to external stimuli. Both animals, 4.5 - 5 
hours after initial darting, were then given naltrexone, atipamezole and 
flumazenil IM, and were standing within six minutes of drug administration. This 
suggests that the BMM combination can immobilise lions for longer than 60 
minutes.  
 
   
 15 
 Physiological parameters recorded in our study were stable and 
cardiovascular parameters were within acceptable limits. Mean heart rate was 
52 beats per minute and bradycardia (defined as < 50 beats per minute) was 
seen in almost half of the lions. This is similar to other studies in lions using α2-
adrenoceptor agonists. Bradyarrhythmias were noted in several lions and have 
also been observed in cheetah immobilised with BMM (Gunkel & Lafortune 
2007). Two lions had a body temperature above 39.9°C and body temperatures 
did not correlate whether lions remained with the carcass or walked off into the 
bush during induction. High body temperatures above 40°C have also been 
observed in lions and exotic carnivores in other studies using α2-adrenoceptor 
agonists (Fahlman et al. 2005; Jacquier et al. 2006; King et al. 2008). 
Hyperthermia may have been caused by warm ambient temperatures or 
interference with normal thermoregulatory mechanisms by α2-adrenoceptor 
agonists or opioids (Handler et al. 1992; Caulkett & Arnemo 2007). It is 
important to measure body temperature and if necessary cool the lions with 
water or provide shade when working during the day. 
 
 Blood gas analyses revealed mild metabolic acidosis, normocapnia, and 
mean PaO2 values of 87 mmHg. Similarly low pH values have been observed in 
free-ranging lions immobilised with different drug combinations (Bush et al. 
1978; Fahlman et al. 2005). Lactate values were within normal limits for 
domestic cats and probably did not contribute to the metabolic acidosis (King 
2004). It has been hypothesized that metabolic acidosis in wild felids is a 
normal occurrence and is correlated to a high protein diet (Fahlman et al. 2005). 
Mean PaCO2 values were within the normal range for domestic cats indicating 
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adequate ventilation (King 2004). Compared to the reference range for 
conscious domestic cats (95 - 115 mmHg) lower mean PaO2 values were seen 
in our lions and 14% of the lions were hypoxaemic (PaO2 < 80mmHg) (King 
2004). Similar PaO2 values were seen in free-ranging lions immobilised with 
tiletamine-zolazepam-medetomidine (Fahlman et al. 2005). In our study, mean 
P(A-a)O2 gradients above 10 mmHg were calculated in both samples indicating 
some degree of ventilation/perfusion imbalance which could have contributed to 
hypoxaemia (King et al. 2008). The mean P(A-a)O2 gradients decreased 
between T1 and T4 and mean PaO2 values increased, but there was no 
significant correlation. It is possible that gas exchange improved over time. In 
lions with hypoxaemia oxygen supplementation is highly recommended.  
 
Pulse oximetry correlated well with the results of the SaO2 values from 
the blood gas analyses. In more than 90 % of the lions pulse oximetry was able 
to give adequate readings and therefore was considered a useful tool for 
additional monitoring when working in the field. In contrast, in our lions there 
was no correlation with PaCO2 values obtained from the blood gas analyses 
and the PE`CO2 as measured by capnographic readings from the nasal air. In 
sedated dogs, ETCO2 monitoring via a nasal catheter using a side-stream 
capnometer provided a clinically acceptable substitute to arterial blood gas 
analysis as a means of monitoring ventilation (Pang et al. 2007). The most likely 
reason for the method failure in our lions was that the endotracheal tube used 
was too short, allowing air to dilute the gases expired (Fukuda et al. 1997).  A 
very low cardiac output would also result in PE`CO2 failing to reflect PaCO2, but 
no other measurement suggested that this was so. Thus, in this study the 
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intranasal endotracheal tube was deemed unreliable in determining actual 
PE`CO2 values, but was practical for measuring respiratory rate.  
 
 The BMM combination was fully reversible using atipamezole, naltrexone 
and flumazenil and administration of these led to a rapid recovery within five 
minutes in 87% of lions. Four lions had longer recovery times to standing (9 - 22 
minutes) and no reasons for this were obvious. Recovery times in our study 
were quicker compared to other drugs combinations used in free-ranging and 
captive lions. In captive African lions immobilised with medetomidine and 
ketamine mean time to walking after atipamezole administration was 53 minutes 
(Tomizawa et al. 1997). Recovery times to standing after atipamezole 
administration were up to 5 hours in free-ranging lions immobilised with 
medetomidine plus tiletamine - zolazepam (Jacquier et al. 2006). Even when 
lower doses of less than 1mg kg-1 tiletamine-zolazepam were used, recovery 
could take 40 minutes (Fahlman et al. 2005). No dissociative agent such as 
ketamine or tiletamine was used in the anaesthetic combination in our lions. 
Therefore all anaesthetic components could be antagonised leading to rapid 
recoveries (Hall et al. 2001). The immobilising drug effects in an adult male lion, 
which was not included in this study due to subcutaneous dart placement, were 
antagonised at 20 minutes after darting and within three minutes the animal was 
able to stand and walk. The rapid and smooth reversibility of the BMM 
combination allows for the rapid termination of an immobilisation procedure 
should an animal experience any anaesthetic associated difficulties. When short 
procedures such as radio collar removal are performed it is practical if 
immobilisation can be reversed without having to wait for the effects of a 
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dissociative agent to wane to avoid emergence excitement (Hall et al. 2001). If 
painful procedures are being performed, it must be taken into consideration that 
the analgesic effects of the BMM combination are fully reversed when using 
atipamezole and naltrexone as antagonists and therefore additional analgesic 
agents are required.  
 
 The mean antagonist doses were for atipamezole 0.26 mg kg-1, 
naltrexone 0.68 mg kg-1 and flumazenil 0.0032 mg kg-1. The IV dose of 
atipamezole used was calculated at 2.5 times the medetomidine dose similar to 
the dosage used in cats. Additionally the same dose of atipamezole was given 
SC with the aim to prolong the duration of effect and hopefully avoid re-
narcotisation. Most other studies in carnivores have given atipamezole at three 
to five times the medetomidine dose either IM or IV (Verstegen & Petcho 1993; 
Larsen et al. 2002; Lafortune et al. 2005; Quandt 2005; Fleming et al. 2006). 
One study performed in free-ranging lions using tiletamine-zolazepam-
medetomidine reports no difference in recovery times if atipamezole was given 
at 2.5 or 5 times the medetomidine dose (Fahlman et al. 2005). The dose of 
naltrexone was higher compared to other studies using 0.25 - 0.5 mg kg-1 in 
wild dogs and cheetah (Lafortune et al. 2005; Fleming et al. 2006). The first 
three lions received only 0.0016 mg kg-1 flumazenil. They appeared quiet after 
reversal, but as soon as they were approached with a vehicle or by another lion 
reacted normally to the stimulus. It was therefore decided to double the 
flumazenil dose, but still very low doses of 0.0032 mg kg-1 flumazenil were used 
in our study compared to other studies in cheetah (0.006 mg kg-1), wild dogs 
(0.005 - 0.01 mg kg-1) and red wolves (0.04 mg kg-1) (Larsen et al. 2002; 
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Lafortune et al. 2005; Fleming et al. 2006). In dogs anaesthetised with BMM 
using higher doses of midazolam, anaesthesia was reversed fully within 15 
minutes using only atipamezole (Verstegen & Petcho 1993). In domestic cats, 
the administration of flumazenil following midazolam and ketamine had little 
overall effect on recovery (Ilkiw et al. 2002). In contrast, in California sea lions a 
mild sedation was seen if BMM was reversed using only atipamezole and 
naltrexone. When flumazenil was used in similar doses to ours no residual 
sedation was observed. Flumazenil has a shorter half-life than midazolam in 
dogs and it is possible that re-sedation may occur after the flumazenil effects 
wane (Lemke 2007). It seems unclear whether flumazenil is necessary in lions 
to fully reverse the effects of BMM, and due to the cost of flumazenil, this factor 
has to be considered when working with such large animals. Sarmazenil, a 
benzodiazepine antagonist, has been used successfully to antagonise the 
effects of zolazepam in cheetahs and lions (Stander & Morkel 1991; Walzer & 
Huber 2002) and could therefore be a valuable alternative to flumazenil (Walzer 
& Huber 2002). Further studies in lions are needed to assess if reversal with 
flumazenil is necessary and if lower doses of naltrexone could be used.  
 
 
In conclusion, the drug combination of BMM proved to be effective in 
immobilising for a period of 45 minutes free-ranging healthy lions of both sexes, 
varying in weight from 81 to 210 kg and aged between two and 10 years. 
Induction following darting was rapid, the animals were not clinically significantly 
compromised due to drug induced physiological changes, there were no 
indications of risk to personnel due to the immobilised animals recovering 
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spontaneously, and the drug effects could be rapidly and completely reversed. 
Some preliminary results suggest that this drug combination may be effective 
for periods longer than 45 minutes and the drug effects can be effectively 
antagonised within 20 minutes after darting. Further research is required to 
confirm these initial results, and to determine the effectiveness of BMM in 
younger animals or lions that are compromised due to old age or other factors 
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Table 1: Description of the scoring system used to categorise the quality of 
induction in free-ranging lions immobilised with butorphanol, medetomidine and 
midazolam by intramuscular injection 
 
Induction score Description  
1  Slight ataxia followed by animal taking one or two attempts to sit 
and/or lie in sternal recumbency without signs of excitement due 
to CNS stimulation or falling over during the process. This is 
followed by a smooth transition into lateral recumbency. 
(Excellent)  
2  Moderate ataxia followed by animal taking one or two attempts 
to sit and or lie in sternal recumbency. There may be some 
initial symptoms of CNS stimulation and/or the animal may 
stumble during the process. (Good) 
3 Severe ataxia followed by animal making numerous attempts to 
sit or lie down. Symptoms of marked CNS stimulation, and/or 
animal stumbles and falls on numerous occasions before 
becoming recumbent. Risk of injury to the animal. (Fair) 
4  Severe ataxia but animal does not become recumbent. Marked 
CNS stimulation, and/or animal stumbles and falls repeatedly. 
Animal requires a second dose of drugs before becoming 
recumbent. (Poor) 
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Table 2: Description of the scoring system used to categorise the quality of 
immobilisation in free-ranging lions immobilised with butorphanol, 





1 Re-dosing required for recumbency. Risk of injury to the 
handler. (Limited effect) 
2 Spontaneous motor activity, struggling during manipulation, 
presence of anal, or palpebral reflexes, responsive to painful 
stimuli. (Deep sedation) 
3 Muscular rigidity, absence of anal reflex but slow palpebral 
reflex, voluntary tail, movements, can be handled safely. (Light 
anaesthesia level) 
4 Smooth, complete relaxation, extractable tongue, loss of pedal 
reflex, no involuntary tail movements, no reaction to blood 
sampling, safe handling. (Moderate anaesthesia level) 
5 Smooth, complete relaxation, extractable tongue, loss of 
palpebral reflex and jaw tone, no involuntary tail movements, no 
reaction to blood sampling, safe handling. (Surgical anaesthesia 
level) 
6 Too deep, absent reflexes, cardiorespiratory depression 
(Excessive level) 
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Table 3: Description of the scoring system used to categorise the quality of 
recovery in free-ranging lions immobilised with butorphanol, 
medetomidine and midazolam by intramuscular injection 
 
Recovery score Description  
1 Animal transitions from lateral to sternal recumbency with 
minimal ataxic movements. Stands in one or two attempts and 
is sufficiently recovered to walk with only slight ataxia. Recovery 
to walking occurs within 10 minutes following administration of 
drug antagonists. (Excellent) 
2 Animal in transitioning from lateral to sternal recumbency 
displays moderate ataxic movements and may take one or two 
attempts. Some imbalance in sternal recumbency and requires 
more than two attempts to stand. Walks with moderate ataxia 
and lack of co-ordination. Recovery to walking occurs within 11 
to 30 minutes following administration of drug antagonists. 
(Good) 
3 Animal makes frequent attempts with severe ataxic movements 
to transition from lateral to sternal recumbency before being 
successful. Severe imbalance in sternal recumbency. Makes 
numerous attempts to stand but frequently falls before being 
successful and displays marked ataxia when walking. Recovery 
to walking in excess of 30 minutes following administration of 
drug antagonists. (Fair) 
4 Animal remains in lateral recumbency for more than 30 minutes 
following the administration of drug antagonists, is not 
responsive to stimuli and makes no attempt to transition to 
sternal recumbency. Or, animal makes a stormy recovery with 
marked ataxia with the potential for injury. May require sedation. 
(Poor)  
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Table 4: Summary of arterial blood gases from free-ranging lions immobilised 
with butorphanol 0.31 mg kg-1, medetomidine 0.052 mg kg-1 and 
midazolam 0.21 mg kg-1 (n = 30) 10 - 15 minutes (T1) and 40 - 45 
minutes (T4) after darting 
 








pH  7.331 0.064 7.335 0.05 
PaCO2 (mmHg) 













HCO3 (mmol/L) 16.3 * 2.6 18.3 3.5 
BE -9 * 3.4 -7 4.3 
SaO2 (%) 94  2.6 95  1.4 
Lactate (mmol/L) 1.53 * 0.8 0.85 0.59 
P(A-a)O2 (mmHg) 22 * 10.9 14 7.5 
*Represents significant differences (P < 0.05) between T1 and T4 
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